Diagnosis and treatment of premenstrual dysphoric disorder

American Family Physician

Volumn 66, Issue 7, 2002, Pages

  Bhatia, Subhash C ^a,b   Bhatia, Shashi K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPRAZOLAM; ANTIDEPRESSANT AGENT; BROMOCRIPTINE; CALCIUM CARBONATE; CITALOPRAM; CLOMIPRAMINE; DANAZOL; DIURETIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; FLUOXETINE; GONADORELIN ANTAGONIST; GOSERELIN; HERBACEOUS AGENT; LEUPRORELIN; MAGNESIUM; MAPROTILINE; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; PRIMROSE OIL; PROGESTERONE; PYRIDOXINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SPIRONOLACTONE; TRYPTOPHAN;

ARTICLE; CLINICAL TRIAL; COGNITION; DRUG COST; DRUG EFFECT; DRUG INTERMITTENT THERAPY; EMOTION; GASTROINTESTINAL DISEASE; HERBAL MEDICINE; HORMONAL THERAPY; HUMAN; LIBIDO; LIFESTYLE; LUTEAL PHASE; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; ORGASM; PREMENSTRUAL DYSPHORIC DISORDER; RATING SCALE; SEXUAL DYSFUNCTION; SIDE EFFECT; SOCIAL PSYCHOLOGY; SYMPTOM; VIRILIZATION; VITAMIN SUPPLEMENTATION; WEIGHT GAIN;

ALGORITHMS; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FEMALE; HEALTH BEHAVIOR; HORMONES; HUMANS; PATIENT EDUCATION; PREMENSTRUAL SYNDROME; SELF-HELP GROUPS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036791810     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Premenstrual syndrome. ACOG committee opinion. No. 155-April 1995 (replaces no. 66, January 1989). Int J Gynaecol Obstet 1995;50:80-4
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: American Psychiatric Association, 1994:715-8.
3. Freeman EW, DeRubeis RJ, Rickels K. Reliability and validity of a daily diary for premenstrual syndrome. Psychiatry Res 1996;65:97-106.
4. Parry BL, Rausch JL. Premenstrual dysphoric disorder. In: Kaplan HI, Sadock BJ, Cancro R, eds. Comprehensive textbook of psychiatry. 6th ed. Baltimore: Williams & Wilkins, 1995:1707-13.
5. Yonkers KA. The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry 1997;58(suppl 15):19-25.
6. Endicott J, Amsterdam J, Eriksson E, Frank E, Freeman E, Hirschfeld R, et al. Is premenstrual dysphoric disorder a distinct clinical entity? J Womens Health Gend Based Med 1999;8:663-79.
7. Kendler KS, Karkowski LM, Corey LA, Neale MC. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry 1998;155:1234-40.
8. Freeman EW, Rickels K, Arredondo F, Kao LC, Pollack SE, Sondheimer SJ. Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant. J Clin Psychopharmacol 1999;19:3-8.
9. Halbreich U, Smoller JW. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 1997;58:399-402.
10. Jermain DM, Preece CK, Sykes RL, Kuehl TJ, Sulak PJ. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Arch Fam Med 1999;8:328-32.
11. Sundblad C, Hedberg MA, Eriksson E. Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome. Neuropsychopharmacology 1993;9:133-45.
12. Steiner M, Korzekwa M, Lamont, J, Wilkins A. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharmacol Bull 1997;33:771-4.
13. Wikander I, Sundblad C, Andersch B, Dagnell I, Zylberstein D, Bengtsson F, et al. Citalopram in premenstrual dysphoria. J Clin Psychopharmacol 1998;18:390-8.
14. Young SA, Hurt PH, Benedek DM, Howard RS. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase. J Clin Psychiatry 1998;59:76-80.
15. Steinberg S, Annable L, Young SN, Liyanage N. A placebo-controlled clinical trial of 1-tryptophan in premenstrual dysphoria. Biol Psychiatry 1999;45:313-20.
16. Wyatt KM, Dimmock PW, Jones PW, Shaughn O'Brien PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome. BMJ 1999;318:1375-81.
17. Freeman EW, Sondheimer SJ, Rickels K. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull 1997;33:303-9.
18. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998;338:209-16.
19. Johnson WG, Carr-Nangle RE, Bergeron KC. Macronutrient intake, eating habits, and exercise as moderators of menstrual distress in healthy women. Psychosom Med 1995;57:324-30.
20. Bowman MA Premenstrual syndrome. In: Dambro MR, Griffith JA, eds. Griffith's 5 minute clinical consult, 2000. Philadelphia: Lippincott Williams & Wilkins, 2000:862-3.
21. Ward MW, Holimon TD. Calcium treatment for premenstrual syndrome. Ann Pharmacother 1999;33: 1356-8.
22. Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol 1998;179:444-52.
23. Christensen AP, Oei TR The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric changes. J Affect Disord 1995;33:57-63.
24. Hardy ML. Herbs of special interest to women. J Am Pharm Assoc (Wash) 2000;40:234-42.
25. Blumenthal M, Gruenwald J, Hall T, Riggins C, Rister R. In: Blumenthal M, Busse WR, eds. The complete German Commission E monographs, therapeutic guide to herbal medicines. Austin, Tex.: American Botanical Council, 1998.
26. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study BMJ 2001;322:134-7.
27. Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, et al. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med 1995;332:1529-34.
28. Diegoli MS, da Fonseca AM, Diegoli CA, Pinotti JA. A double-blind trial of four medications to treat severe premenstrual syndrome. Int J Gynaecol Obstet 1998;62:63-7.
29. Romano S, Judge R, Dillon J, Shuler C, Sundell K. The role of fluoxetine in the treatment of premenstrual dysphoric disorder. Clin Ther 1999;21:615-33.
30. Eriksson E, Hedberg MA, Andersch B, Sunblad C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 1995;12:167-76.
31. Freeman EW, Rickels K, Sondheimer SJ, Polansky M. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder. Arch Gen Psychiatry 1999;56:932-9.
32. Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J, Frank E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. JAMA 1997;278:983-8.
33. Cohen LS. Sertraline for premenstrual dysphoric disorder. JAMA 1998;279:357-8.
34. Sundblad C, Modigh K, Andersch B, Eriksson E. Clomipramine effectively reduces premenstrual irritability and dysphoria. Acta Psychiatr Scand 1992; 85:39-47.
35. Dimmock PW, Wyatt KM, Jones PW, O'Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome. Lancet 2000;356:1131-6.
36. Berger CP, Presser B. Alprazolam in the treatment of two subsamples of patients with late luteal phase dysphoric disorder. Obstet Gynecol 1994;84:379-85.
37. Freeman EW, Rickels K, Sondheimer SJ, Polansky M. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 1995;274:51-7.
38. Hammarbäck S, Bäckstrom T. Induced anovulation as treatment of premenstrual tension syndrome. Acta Obstet Gynecol Scand 1988;67:159-66.
39. Leather AT, Studd JW, Watson NR, Holland EF. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy. Gynecol Endocrinol 1999;13:48-55.
40. Brown CS, Ling FW, Andersen RN, Farmer RG, Arheart KL. Efficacy of depot leuprolide in premenstrual syndrome. Obstet Gynecol 1994;84:779-86.
41. Hahn PM, Van Vugt DA, Reid RL. A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology 1995;20:193-209.
42. Magill PJ. Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome. Br J Gen Pract 1995;45:589-93.
43. Vanselow W, Dennerstein L, Greenwood KM, de Lignieres B. Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration. J Psychosom Obstet Gynaecol 1996;17:29-38.
44. Wang M, Hammarbäck S, Lindhe BA, Bäckstrom T. Treatment of premenstrual syndrome by spironolactone. Acta Obstet Gynecol Scand 1995;74:803-8.
45. Meden-Vrtovec H, Vujic D. Bromocriptine (Bromergon, Lek) in the management of premenstrual syndrome. Clin Exp Obstet Gynecol 1992;19:242-8.